True Luu Mcmahan, MD - Medicare Emergency Medicine in Laguna Beach, CA

True Luu Mcmahan, MD is a medicare enrolled "Emergency Medicine" physician in Laguna Beach, California. She went to Baylor College Of Medicine and graduated in 1998 and has 26 years of diverse experience with area of expertise as Emergency Medicine. She is a member of the group practice Cep America - California and her current practice location is 31872 South Coast Highway, Laguna Beach, California. You can reach out to her office (for appointments etc.) via phone at (949) 449-7193.

True Luu Mcmahan is licensed to practice in California (license number A70635) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1114977683.

Contact Information

True Luu Mcmahan, MD
31872 South Coast Highway,
Laguna Beach, CA 92651
(949) 449-7193
Not Available



Physician's Profile

Full NameTrue Luu Mcmahan
GenderFemale
SpecialityEmergency Medicine
Experience26 Years
Location31872 South Coast Highway, Laguna Beach, California
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • True Luu Mcmahan attended and graduated from Baylor College Of Medicine in 1998
  NPI Data:
  • NPI Number: 1114977683
  • Provider Enumeration Date: 05/12/2006
  • Last Update Date: 05/02/2018
  Medicare PECOS Information:
  • PECOS PAC ID: 5991732455
  • Enrollment ID: I20050726001005

Medical Identifiers

Medical identifiers for True Luu Mcmahan such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1114977683NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207P00000XEmergency Medicine A70635 (California)Primary
207PH0002XEmergency Medicine - Hospice And Palliative Medicine A70635 (California)Secondary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Memorialcare Hospice And Palliative ServicesLaguna hills, CAHospice
Garden Grove Hospital & Medical CenterGarden grove, CAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Cep America - California6103739131954

News Archive

Novel protein interactions with ACE2 disrupted by SARS-CoV-2, contributes to COVID-19 pathologies

A severe and often fatal immune response called a "cytokine storm" can occur following SARS-CoV-2 infection. Some patients suffer from a range of complications several months after testing negative for SARS-CoV-2, and this is called ‘Long Haul' or ‘Long' COVID-19. The causes behind this phenomenon are not well understood.

Physicians suspect that chemotherapy can accelerate aging process

Physicians have long suspected that chemotherapy can accelerate the aging process in patients treated for cancer. Using a test developed at UNC Lineberger Comprehensive Cancer Center to determine molecular aging, UNC oncologists have directly measured the impact of anti-cancer chemotherapy drugs on biological aging.

iCo Therapeutics announces $4,000,000 brokered private placement

iCo Therapeutics Inc. (the "Company") is pleased to announce that further to its press release issued October 20, 2009 announcing a $4,000,000 brokered private placement (the "Offering") co-led by Loewen, Ondaatje, McCutcheon Limited and Versant Partners Inc. (collectively, the "Agents"), the Company has completed the first tranche of the Offering through the issuance of 6,000,000 common shares of Company (the "Shares"). The Shares were issued at a price of $0.48 per share for gross proceeds of $2,880,000.

Scientists reprogram amniotic fluid cells without introduction of extra genes

Stem cells found in amniotic fluid can be transformed into a more versatile state similar to embryonic stem cells, according to a study published today in the journal Molecular Therapy. Scientists from Imperial College London and the UCL Institute of Child Health succeeded in reprogramming amniotic fluid cells without having to introduce extra genes.

Read more Medical News

› Verified 9 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. True Luu Mcmahan allows following entities to bill medicare on her behalf.
Entity NameCep America - California
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1023063542
PECOS PAC ID: 6103739131
Enrollment ID: O20031106000520

News Archive

Novel protein interactions with ACE2 disrupted by SARS-CoV-2, contributes to COVID-19 pathologies

A severe and often fatal immune response called a "cytokine storm" can occur following SARS-CoV-2 infection. Some patients suffer from a range of complications several months after testing negative for SARS-CoV-2, and this is called ‘Long Haul' or ‘Long' COVID-19. The causes behind this phenomenon are not well understood.

Physicians suspect that chemotherapy can accelerate aging process

Physicians have long suspected that chemotherapy can accelerate the aging process in patients treated for cancer. Using a test developed at UNC Lineberger Comprehensive Cancer Center to determine molecular aging, UNC oncologists have directly measured the impact of anti-cancer chemotherapy drugs on biological aging.

iCo Therapeutics announces $4,000,000 brokered private placement

iCo Therapeutics Inc. (the "Company") is pleased to announce that further to its press release issued October 20, 2009 announcing a $4,000,000 brokered private placement (the "Offering") co-led by Loewen, Ondaatje, McCutcheon Limited and Versant Partners Inc. (collectively, the "Agents"), the Company has completed the first tranche of the Offering through the issuance of 6,000,000 common shares of Company (the "Shares"). The Shares were issued at a price of $0.48 per share for gross proceeds of $2,880,000.

Scientists reprogram amniotic fluid cells without introduction of extra genes

Stem cells found in amniotic fluid can be transformed into a more versatile state similar to embryonic stem cells, according to a study published today in the journal Molecular Therapy. Scientists from Imperial College London and the UCL Institute of Child Health succeeded in reprogramming amniotic fluid cells without having to introduce extra genes.

Read more Medical News

› Verified 9 days ago

Entity NameCep America - California
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1548667843
PECOS PAC ID: 6103739131
Enrollment ID: O20040121000458

News Archive

Novel protein interactions with ACE2 disrupted by SARS-CoV-2, contributes to COVID-19 pathologies

A severe and often fatal immune response called a "cytokine storm" can occur following SARS-CoV-2 infection. Some patients suffer from a range of complications several months after testing negative for SARS-CoV-2, and this is called ‘Long Haul' or ‘Long' COVID-19. The causes behind this phenomenon are not well understood.

Physicians suspect that chemotherapy can accelerate aging process

Physicians have long suspected that chemotherapy can accelerate the aging process in patients treated for cancer. Using a test developed at UNC Lineberger Comprehensive Cancer Center to determine molecular aging, UNC oncologists have directly measured the impact of anti-cancer chemotherapy drugs on biological aging.

iCo Therapeutics announces $4,000,000 brokered private placement

iCo Therapeutics Inc. (the "Company") is pleased to announce that further to its press release issued October 20, 2009 announcing a $4,000,000 brokered private placement (the "Offering") co-led by Loewen, Ondaatje, McCutcheon Limited and Versant Partners Inc. (collectively, the "Agents"), the Company has completed the first tranche of the Offering through the issuance of 6,000,000 common shares of Company (the "Shares"). The Shares were issued at a price of $0.48 per share for gross proceeds of $2,880,000.

Scientists reprogram amniotic fluid cells without introduction of extra genes

Stem cells found in amniotic fluid can be transformed into a more versatile state similar to embryonic stem cells, according to a study published today in the journal Molecular Therapy. Scientists from Imperial College London and the UCL Institute of Child Health succeeded in reprogramming amniotic fluid cells without having to introduce extra genes.

Read more Medical News

› Verified 9 days ago

Entity NameMission Viejo Emergency Medical Associates, Inc.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1134355597
PECOS PAC ID: 7315090271
Enrollment ID: O20090725000046

News Archive

Novel protein interactions with ACE2 disrupted by SARS-CoV-2, contributes to COVID-19 pathologies

A severe and often fatal immune response called a "cytokine storm" can occur following SARS-CoV-2 infection. Some patients suffer from a range of complications several months after testing negative for SARS-CoV-2, and this is called ‘Long Haul' or ‘Long' COVID-19. The causes behind this phenomenon are not well understood.

Physicians suspect that chemotherapy can accelerate aging process

Physicians have long suspected that chemotherapy can accelerate the aging process in patients treated for cancer. Using a test developed at UNC Lineberger Comprehensive Cancer Center to determine molecular aging, UNC oncologists have directly measured the impact of anti-cancer chemotherapy drugs on biological aging.

iCo Therapeutics announces $4,000,000 brokered private placement

iCo Therapeutics Inc. (the "Company") is pleased to announce that further to its press release issued October 20, 2009 announcing a $4,000,000 brokered private placement (the "Offering") co-led by Loewen, Ondaatje, McCutcheon Limited and Versant Partners Inc. (collectively, the "Agents"), the Company has completed the first tranche of the Offering through the issuance of 6,000,000 common shares of Company (the "Shares"). The Shares were issued at a price of $0.48 per share for gross proceeds of $2,880,000.

Scientists reprogram amniotic fluid cells without introduction of extra genes

Stem cells found in amniotic fluid can be transformed into a more versatile state similar to embryonic stem cells, according to a study published today in the journal Molecular Therapy. Scientists from Imperial College London and the UCL Institute of Child Health succeeded in reprogramming amniotic fluid cells without having to introduce extra genes.

Read more Medical News

› Verified 9 days ago

Entity NameGlenndoc, Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1417526112
PECOS PAC ID: 9133519366
Enrollment ID: O20211202001626

News Archive

Novel protein interactions with ACE2 disrupted by SARS-CoV-2, contributes to COVID-19 pathologies

A severe and often fatal immune response called a "cytokine storm" can occur following SARS-CoV-2 infection. Some patients suffer from a range of complications several months after testing negative for SARS-CoV-2, and this is called ‘Long Haul' or ‘Long' COVID-19. The causes behind this phenomenon are not well understood.

Physicians suspect that chemotherapy can accelerate aging process

Physicians have long suspected that chemotherapy can accelerate the aging process in patients treated for cancer. Using a test developed at UNC Lineberger Comprehensive Cancer Center to determine molecular aging, UNC oncologists have directly measured the impact of anti-cancer chemotherapy drugs on biological aging.

iCo Therapeutics announces $4,000,000 brokered private placement

iCo Therapeutics Inc. (the "Company") is pleased to announce that further to its press release issued October 20, 2009 announcing a $4,000,000 brokered private placement (the "Offering") co-led by Loewen, Ondaatje, McCutcheon Limited and Versant Partners Inc. (collectively, the "Agents"), the Company has completed the first tranche of the Offering through the issuance of 6,000,000 common shares of Company (the "Shares"). The Shares were issued at a price of $0.48 per share for gross proceeds of $2,880,000.

Scientists reprogram amniotic fluid cells without introduction of extra genes

Stem cells found in amniotic fluid can be transformed into a more versatile state similar to embryonic stem cells, according to a study published today in the journal Molecular Therapy. Scientists from Imperial College London and the UCL Institute of Child Health succeeded in reprogramming amniotic fluid cells without having to introduce extra genes.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. True Luu Mcmahan is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
True Luu Mcmahan, MD
2100 Powell Street Ste 920,
Emeryville, CA 94608-1803

Ph: (510) 350-2777
True Luu Mcmahan, MD
31872 South Coast Highway,
Laguna Beach, CA 92651

Ph: (949) 449-7193

News Archive

Novel protein interactions with ACE2 disrupted by SARS-CoV-2, contributes to COVID-19 pathologies

A severe and often fatal immune response called a "cytokine storm" can occur following SARS-CoV-2 infection. Some patients suffer from a range of complications several months after testing negative for SARS-CoV-2, and this is called ‘Long Haul' or ‘Long' COVID-19. The causes behind this phenomenon are not well understood.

Physicians suspect that chemotherapy can accelerate aging process

Physicians have long suspected that chemotherapy can accelerate the aging process in patients treated for cancer. Using a test developed at UNC Lineberger Comprehensive Cancer Center to determine molecular aging, UNC oncologists have directly measured the impact of anti-cancer chemotherapy drugs on biological aging.

iCo Therapeutics announces $4,000,000 brokered private placement

iCo Therapeutics Inc. (the "Company") is pleased to announce that further to its press release issued October 20, 2009 announcing a $4,000,000 brokered private placement (the "Offering") co-led by Loewen, Ondaatje, McCutcheon Limited and Versant Partners Inc. (collectively, the "Agents"), the Company has completed the first tranche of the Offering through the issuance of 6,000,000 common shares of Company (the "Shares"). The Shares were issued at a price of $0.48 per share for gross proceeds of $2,880,000.

Scientists reprogram amniotic fluid cells without introduction of extra genes

Stem cells found in amniotic fluid can be transformed into a more versatile state similar to embryonic stem cells, according to a study published today in the journal Molecular Therapy. Scientists from Imperial College London and the UCL Institute of Child Health succeeded in reprogramming amniotic fluid cells without having to introduce extra genes.

Read more News

› Verified 9 days ago


Emergency Medicine Doctors in Laguna Beach, CA

Susan K. Munden, M.D.
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 31872 Coast Hwy, Laguna Beach, CA 92651
Phone: 949-499-1311    
Dr. Timothy Earl Korber, M.D.
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 825 Emerald Bay, Laguna Beach, CA 92651
Phone: 949-494-5154    
Michael George Bower, M.D.
Emergency Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 31872 Coast Hwy, Laguna Beach, CA 92651
Phone: 949-499-1311    
Lewis M Moss, MD
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 364 Ocean Ave, Laguna Beach, CA 92651
Phone: 949-557-0610    
Dr. William Carl Anderson, MD
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 364 Ocean Avenue, Laguna Beach, CA 92651
Phone: 949-494-3740    
Marc David Taub, M.D
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 31872 South Coast Highway, Laguna Beach, CA 92651
Phone: 949-499-1311    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.